PRCT

Procept Biorobotics Corp

NASDAQ: PRCT · HEALTHCARE · MEDICAL DEVICES

$20.38

+1.54% today

Updated 2026-09-11

Market cap

$1.18B

P/E ratio

—

P/S ratio

3.50x

EPS (TTM)

$-1.90

Dividend yield

—

52W range

$17 – $40

Volume

1.5M

Market cap

$1.18B

P/E ratio

—

P/S ratio

3.50x

EPS (TTM)

$-1.90

Dividend yield

—

52W range

$17 – $40

Volume

1.5M

Procept Biorobotics Corp (PRCT) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price

$20.38

12-Month target

—

2030 Target

—

Intrinsic (DCF)

—

Financial forecast

Metric	2021	2022	2023	2024	2025
Revenue	$0.0B	$0.1B	$0.1B	$0.2B	$0.3B
EPS	—	—	—	—	—

CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -32.50%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.